personalized medicine

June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

By Bill Snyder
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.

By Leigh MacMillan
March 31, 2014

E-records shed light on drug response

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.

By Leigh MacMillan
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

By Bill Snyder
March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.

By Nancy Humphrey
March 1, 2013

Zeppos reflects on first five years as chancellor

The One Vanderbilt transformation continues as Nicholas S. Zeppos marks five years as chancellor. Read the story and watch video of Zeppos discussing the opportunities and challenges facing Vanderbilt today.

By VUMC News and Communications
September 27, 2012

AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.
By Bill Snyder
September 6, 2012

Personalized medicine focus of Chancellor’s Lecture

The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.
By Bill Snyder
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
By Craig Boerner
April 15, 2011

Vanderbilt: Laboratory for health care reform

By Bill Snyder
March 3, 2011

Vanderbilt-Ingram Cancer Center launches online genetic research tool

A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.
By VUMC News and Communications
September 30, 2010

Video: Personalized Medicine and the Future of Health Care

By VUMC News and Communications
1 2 3 4 5